Michel Véron

3.2k citations
79 papers · 2.5k indexed · h-index 34
Topics
Mechanisms of cancer metastasis (25 papers)Cancer Mechanisms and Therapy (14 papers)MXene and MAX Phase Materials (13 papers)

In The Last Decade

Michel Véron

78 papers receiving 2.4k citations

Peers

Michel Véron
Comparison fields: 5 of 111
  • Molecular Biology 1.6k
  • Materials Chemistry 407
  • Cancer Research 368
  • Cell Biology 367
  • Infectious Diseases 304
Replace Barbara Wolff with:
Barbara Wolff Austria
Judith K. Christman United States
Carmen Rivas Spain
Roberto Weinmann United States
Marianne Oskarsson United States
Christian Schölz Germany
Yan‐Hwa Wu Lee Taiwan
Kathleen M. Downey United States
Mark O. J. Olson United States
Carlo M. Nalin United States
Michel Véron relative to Barbara Wolff Austria Barbara Wolff's profile →
Citations per field
00.5×11×
Barbara Wolff · 1×
Citations per year

Countries citing papers authored by Michel Véron

Since Specialization
Citations

This map shows the geographic impact of Michel Véron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Véron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Véron more than expected).

Fields of papers citing papers by Michel Véron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Véron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Véron. The network helps show where Michel Véron may publish in the future.

Co-authorship network of co-authors of Michel Véron

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Véron. A scholar is included among the top collaborators of Michel Véron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Véron. Michel Véron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 12
2 34
3 32
4 37
5 52
6 2
7 61
8 24
9 3
10 36
11 3
12 39
13 4
14 74
15 6
16 8
17 35
18 8
19 8
20 5

About Michel Véron

Michel Véron is a scholar working on Cell Biology, Cancer Research and Pathology and Forensic Medicine, having authored 79 papers that have together received 2.5k indexed citations. Recurring topics across this work include Mechanisms of cancer metastasis (25 papers), Cancer Mechanisms and Therapy (14 papers) and MXene and MAX Phase Materials (13 papers). The work is most often cited by research in Virology (198 citations), Cancer Research (368 citations) and Molecular Biology (1.6k citations). Michel Véron has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Fabrice Agou, Joël Janin, Dominique Deville‐Bonne, Georges N. Cohen, Benoı̂t Schneider, François Traincard, Marie‐Noëlle Simon, Jean de Gunzburg, Alain Israël and Robert R. Kay. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026